Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Medicinova Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 34 | 30 | −4 |
| Shares | 5.38M | 5.01M | −374.8K (−7.0%) |
| Value | $12.4M | $10.5M | −$1.93M (−15.6%) |
New holders (3)
Institutions that held Medicinova Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Capricorn Fund Managers Ltd | 30,459 | $63.7K | 0.02% |
| Susquehanna International Group, LLP | 13,134 | $27.4K | 0.00% |
| Qube Research & Technologies Ltd | 32 | $67 | 0.00% |
Sold out (7)
Institutions that held Medicinova Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bank of Montreal | 127,300 | $310.6K |
| UBS Group AG | 91,828 | $211.2K |
| Ergoteles LLC | 31,117 | $71.6K |
| Bank Julius Baer & Co. Ltd, Zurich | 18,650 | $43.0K |
| Citadel Advisors LLC | 15,492 | $35.6K |
| Royal Bank of Canada | 289 | $1.00K |
| GWM Advisors LLC | 8 | $18 |